MANKIND PHARMA
🇮🇳India
- Country
- 🇮🇳India
- Ownership
- -
- Established
- 1995-01-01
- Employees
- -
- Market Cap
- $11.5B
Bioequivalence Study With Clinical Endpoint Comparing Bimatoprost Ophthalmic Solution 0.01% to LUMIGAN® In The Treatment of Chronic Open-Angle Glaucoma
Phase 3
Completed
- Conditions
- Glaucoma, Open-Angle
- Interventions
- Drug: Test - Bimatoprost 0.01% Ophthalmic SolutionDrug: Reference - LUMIGAN® (Bimatoprost 0.01% Ophthalmic Solution)
- First Posted Date
- 2021-05-18
- Last Posted Date
- 2022-12-13
- Lead Sponsor
- Mankind Pharma Limited
- Target Recruit Count
- 310
- Registration Number
- NCT04890106
- Locations
- 🇺🇸
CBCC Global Research Site:011, Bakersfield, California, United States
🇺🇸CBCC Global Research Site 017, Newport Beach, California, United States
🇺🇸CBCC Global Research Site: 012, Newport Beach, California, United States
© Copyright 2025. All Rights Reserved by MedPath